Therapy Areas: Central Nervous System
28 July 2021 - - US-based clinical-stage biotechnology company Lyndra Therapeutics' LYN-014 oral, ultra-long-acting, extended-release levomethadone capsule in development for the weekly treatment...
19 July 2021 - - US-based pharmaceutical company Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has received Abbreviated New Drug Application approval from the US Food and Drug Administration for the gener...
14 July 2021 - - US-based biotechnology company Ionis Pharmaceuticals (NASDAQ: IONS) has exercised its option and entered into an exclusive worldwide license and collaboration agreement with UK-based ...
13 July 2021 - Servier, a global independent pharmaceutical Group, and Nymirum, a company focused on RNA-targeted small molecules, announced on Monday that they have signed a strategic collaboration t...
12 July 2021 - - The US Food and Drug Administration has granted Fast Track Designation to French gene therapy platform company Lysogene's (PAR: LYS) (FR0013233475 LYS) LYS-GM101 program, which i...
9 July 2021 - - UK-based Exscientia has received a grant from the Bill and Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator, the company said....
Related Headlines